Notably, we observed elevated somatic BRCA1/2 rates in several non-BRCA-associated lineages such as uterine sarcoma (7.3%), small cell lung cancer (2.6%), and bladder (1.7%) compared to those in BRCA-associated lineages. This evidence concerns the gene BRCA1 and uterine corpus sarcoma.